TNBC

February 20, 2015February 20, 2015

Methylome Could Improve Triple Negative Breast Cancer Diagnosis

News

A new study published in the journal Nature Communications describes a breast cancer DNA “methylome,” a new way of looking not just at the DNA sequence, but also how it may have been altered by ... Read more

January 9, 2015January 9, 2015

Drug For Triple-Negative Breast Cancer Treatment Received Fast Track Designation By FDA

News

Immunomedics, Inc. has announced its sacituzumab govitecan research received the U.S. Food and Drug Administration (FDA) designation of Fast Track development program for the treatment of triple negative breast cancer ... Read more

December 12, 2014December 12, 2014

miR-21 Serves as Prognostic Biomarker in Triple-Negative Breast Cancer

Breast Cancer News, News

Patients with triple-negative breast cancer (TNBC), or those individuals with breast cancer cells that do not express estrogen, progesterone, or human epidermal growth factor receptor 2 receptors (ER-/PR-/HER-), may be ... Read more

December 11, 2014December 11, 2014

Study Evaluates Use of HIFs Inhibitors For The Treatment Of Triple Negative Breast Cancer

News

A new study entitled “Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells” highlights the potential of administrating hypoxia-inducible factors (HIFs) inhibitors with chemotherapy to improve triple ... Read more

December 8, 2014December 8, 2014

Study Finds Triple-Negative Breast Cancer Patients Benefit From Genetic Screening

News

In a study published in the Journal of Clinical Oncology, researchers found that patients diagnosed with triple-negative breast cancer (TNBC) should be tested for mutations in known predisposition genes, such ... Read more